Functional Launch Plan Final Milestone Health
Overall
Nov 2025 → Jan 2026,
Delay: 3 months | Cost: $50m
Marketing
Market Access
Nov 2025 → Jan 2026,
Delay: 3 months | Cost: $50m
Payor Pricing Strategy
EU Payor Pricing
US Payor Pricing
Task Mitigation / Impact Action
US Payor Pricing Review & rework the competitor pricing for 3 similar molecules
Impact: Favorable Formulary Tiering, reducing delay by 2 months
Patient Journey